Shanghai United Imaging Intelligence
About Shanghai United Imaging Intelligence
Shanghai United Imaging Intelligence (UII) is a prominent healthcare AI company and a subsidiary of the larger United Imaging Group, founded in 2017. The company specializes in developing and delivering a comprehensive suite of artificial intelligence solutions for the medical field, aiming to transform healthcare delivery. UII’s offerings span the entire diagnostic and treatment process, from initial screening and diagnosis to treatment planning and follow-up assessments. Their AI technologies are designed to empower all modalities of medical equipment, including CT, MR, PET, and X-ray, as well as radiotherapy equipment, making imaging and treatment faster, more effective, safer, and more cost-efficient.
For physicians, UII’s AI solutions are integrated into clinical workflows to enhance accuracy and efficiency. The company has developed over 10 AI platforms and more than 100 AI applications, with over 50 AI-assisted applications seamlessly integrated to optimize and streamline clinical workflows. These applications cover various diseases across different anatomical regions and clinical scenarios. UII also supports biomedical research by providing platforms with a diverse array of medical AI algorithms and specialized toolboxes, particularly in neurology, cardiology, and PET imaging. Their products have received significant regulatory clearances, including NMPA Class III, CE, and FDA approvals, and are deployed in thousands of hospitals globally.
Focus Areas
Business Intelligence
| Technology | uAI platform, uAI Clinical Portal, uAI Easy Triage platform, uVERA platform, multimodal foundation models, large language models (LLMs), deep learning, AI agents, AI-Enabled Intelligent Scanning, Low-Dose CT Imaging, ACS High-speed MRI scanning |
What Physicians Need to Know
For physicians, Shanghai United Imaging Intelligence offers tools designed to significantly enhance diagnostic accuracy and efficiency. Their AI-driven triage systems can prioritize critical cases, ensuring timely intervention. The extensive portfolio of over 100 AI applications across various modalities and disease areas provides comprehensive support from screening to follow-up, reducing manual workload and offering quantitative insights that are difficult to obtain manually. The integration of AI into imaging equipment leads to faster scans, lower radiation doses, and improved image quality, benefiting patient comfort and diagnostic confidence. Furthermore, their advanced AI agents and multimodal foundation models are moving towards more intelligent human-AI partnerships, offering automated reporting and advanced reasoning capabilities to support complex clinical decision-making and surgical planning. This allows physicians to focus more on patient care and less on repetitive tasks, ultimately leading to improved patient outcomes.
Shanghai United Imaging Intelligence's AI solutions are seamlessly integrated to optimize and streamline the entire clinical workflow. They are a subsidiary of United Imaging Group, which develops and produces a full portfolio of advanced medical imaging and radiotherapy equipment, allowing for deep integration of AI into their core software across all modalities. UII's uAI Clinical Portal (uCP) is a unified platform comprising more than 60 AI applications, demonstrating deep technological readiness for real-world clinical integration. They have also established research collaborations with institutions like Massachusetts General Hospital.
What the Web Says
Shanghai United Imaging Intelligence (UII) is a subsidiary of United Imaging Group, specializing in artificial intelligence solutions for healthcare. The company, founded in 2017, focuses on developing AI for medical imaging, radiotherapy equipment, and intelligent digital solutions, aiming to transform healthcare delivery from screening and diagnosis to treatment and follow-up. UII has a significant global presence with its AI products used in over 4,000 medical institutions and has received numerous international certifications for its AI applications.
Overall: MixedStrengths
- Aggressive market strategy with incentives like multi-year comprehensive maintenance contracts at no additional cost.
- Product lineup offers fully-loaded configurations as standard, unlike competitors who reserve higher-end specifications for premium models.
- AI solutions enhance accuracy and efficiency in clinical workflows.
- Expands opportunities for biomedical research and collaborations.
- Enables medical equipment with unprecedented capabilities and user-friendliness.
- Strong regulatory foundation with numerous FDA and CE certifications for AI applications.
Limitations
- Concerns about the impact of trade wars and tariffs on parts availability for US customers.
- Cybersecurity concerns due to the company's Chinese origins and potential for government access or control.
- Some employee reviews mention poor treatment of staff in China, disastrous management, and long hours.
- Allegations of unfulfilled promises regarding performance and year-end bonuses for employees.
- Ties to the Chinese Communist Party and links to industrial espionage have been reported.
Based on reviews from: G2, Glassdoor, Capterra, Reddit, Washington Examiner, Indeed.com, Investing.com, MCRA, Health AI Register, AuntMinnie, PR Newswire, Wikipedia, Medical News Bulletin, 36氪
Last updated: 2026-10-20
Videos
News, demos, and interviews about Shanghai United Imaging Intelligence.
Videos load interactively. If none appear, search YouTube for Shanghai United Imaging Intelligence →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Koios Care is a neurology-focused digital medicine company based in Antwerp, Belgium, specializing in AI-powered platforms. The company aims to revolutionize the management of neurological and chronic conditions, with an initial focus on Parkinson’s Disease. Koios Care’s platform utilizes everyday devices like smartphones and smartwatches to passively collect and analyze data, transforming it into objective, […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]